Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome
Recruiting
N/A
Interventional Study
Dumping Syndrome
Post-bariatric Hypoglycemia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 60 (estimated)
- Sponsor
- Kaiser Clinic and Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Late dumping syndrome is a common complication following Roux-en-Y gastric bypass, characterized by postprandial hypoglycemia with significant impact on patient safety and quality of life. Traditional capillary glucose monitoring has limited ability to detect rapid glycemic fluctuations.
This prospective randomized study aims to evaluate the efficacy and safety of the iCan i3 continuous glucose m…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18-65 years
* History of Roux-en-Y gastric bypass ≥12 months
* Clinical diagnosis of late dumping syndrome
* Stable body weight (\<5% variation in last 3 months)
* Ability to provide informed consent
Exclusion Criteria:
* Diagnosis of diabetes mellitus under treatment
* …
Contacts